Florida Gov. Ron DeSantis (R), in a press release late Monday, called on the President Joe Biden administration for revoking the Emergency Use Authorization (EUA) for Regeneron’s and Eli Lilly’s monoclonal antibody treatments. The Food and Drug Administration quietly revoked the EUA leading to all of Florida’s state-run monoclonal treatment sites to be shut down.
Read More
Florida Surgeon General Dr. Joseph Ladapo sent a letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra saying the Biden Administration is “actively preventing” the shipments on Regeneron’s monoclonal antibody treatments to states, including Florida.
Read More
Florida Gov. Ron DeSantis has spent two months cross-crossing the state promoting sites and clinics that offer monoclonal antibody treatments, an increasingly popular alternative to vaccines for protection from COVID-19.
In fact, so popular that last week, the U.S. Department of Health & Human Services (DHS), while increasing overall supplies by 50%, from 100,000 to 150,000 doses a week nationwide, but capping the number of doses being delivered to Florida and six other Southern states that had previously consumed more than 70% of the nation’s monoclonal antibody treatments.
Read More
Governor DeSantis expressed his support for Regeneron’s monoclonal antibody treatment Thursday, as COVID cases and the number of hospitalizations continue to surge in Florida.
According to DeSantis, “These treatments have been proven successful, with clinical trials resulting in a 70% reduction in hospitalization and death for COVID patients,” especially those who have higher risk for severe complications due to age or preexisting medical conditions.
As reported by the Food and Drug Administration (FDA), “Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses.” The treatment is meant for individuals who have tested positive or recovered from COVID.
Read More